NASDAQ:ELYM - Nasdaq - US28658R1068 - Common Stock
TTM (2024-6-30) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | ||||
---|---|---|---|---|---|---|---|---|
Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
Operating Expenses | 67.21M | 21.47M | 45.14M | 35.67M | 20.93M | |||
Research and Development | 57.80M | 11.58M | 26.21M | 23.32M | 18.50M | |||
Selling, General, and Administrative Expenses | 9.41M | 9.89M | 18.92M | 12.35M | 2.43M | |||
Operating Income | -67.21M | -21.47M | -45.14M | -35.67M | -20.93M | |||
Interest Income/Expense | 5.30M | 5.16M | -1.48M | -170.00K | 260.00K | |||
Other Income/Expense | N/A | N/A | 1.38M | -11.64M | 0.00 | |||
Non Recurring Items | N/A | -18.81M | N/A | N/A | N/A | |||
Income Before Taxes | -64.19M | -35.12M | -45.24M | -47.48M | -20.67M | |||
Net Income | -64.19M | -35.12M | -45.24M | -52.03M | -22.95M | |||
Per Share Data | ||||||||
EPS Diluted Total Ops | -2.15 | -1.30 | -1.72 | -4.24 | -0.91 | |||
Non GAAP EPS | N/A | N/A | -1.72 | N/A | N/A | |||
Statistics |
All data in USD